Your browser doesn't support javascript.
loading
Polycomb genes are associated with response to imatinib in chronic myeloid leukemia.
Crea, Francesco; Di Paolo, Antonello; Liu, Hui Hsuan; Polillo, Marialuisa; Clermont, Pier-Luc; Guerrini, Francesca; Ciabatti, Elena; Ricci, Federica; Baratè, Claudia; Fontanelli, Giulia; Barsotti, Sara; Morganti, Riccardo; Danesi, Romano; Wang, Yuzhuo; Petrini, Mario; Galimberti, Sara; Helgason, Cheryl D.
Afiliação
  • Crea F; Experimental Therapeutics, BCCA Research Centre, 675 W 10th Avenue, Vancouver, BC, V5Z 1L3, Canada.
  • Di Paolo A; Vancouver Prostate Centre, Vancouver General Hospital, 2660 Oak Street, Vancouver, BC, V6H 3Z6, Canada.
  • Liu HH; Department of Life Health & Chemical Sciences, The Open University, UK.
  • Polillo M; Department of Clinical & Experimental Medicine, Section of Pharmacology, University of Pisa, Pisa, Italy.
  • Clermont PL; Experimental Therapeutics, BCCA Research Centre, 675 W 10th Avenue, Vancouver, BC, V5Z 1L3, Canada.
  • Guerrini F; Department of Clinical & Experimental Medicine, Section of Pharmacology, University of Pisa, Pisa, Italy.
  • Ciabatti E; Experimental Therapeutics, BCCA Research Centre, 675 W 10th Avenue, Vancouver, BC, V5Z 1L3, Canada.
  • Ricci F; Department of Clinical & Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy.
  • Baratè C; Department of Clinical & Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy.
  • Fontanelli G; Department of Clinical & Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy.
  • Barsotti S; Department of Clinical & Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy.
  • Morganti R; Department of Clinical & Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy.
  • Danesi R; Department of Clinical & Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy.
  • Wang Y; Department of Clinical & Experimental Medicine, Section of Statistics, University of Pisa, Pisa, Italy.
  • Petrini M; Department of Clinical & Experimental Medicine, Section of Pharmacology, University of Pisa, Pisa, Italy.
  • Galimberti S; Experimental Therapeutics, BCCA Research Centre, 675 W 10th Avenue, Vancouver, BC, V5Z 1L3, Canada.
  • Helgason CD; Vancouver Prostate Centre, Vancouver General Hospital, 2660 Oak Street, Vancouver, BC, V6H 3Z6, Canada.
Epigenomics ; 7(5): 757-65, 2015 Aug.
Article em En | MEDLINE | ID: mdl-26343356
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Regulação Leucêmica da Expressão Gênica / Proteínas do Grupo Polycomb / Mesilato de Imatinib Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Epigenomics Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Regulação Leucêmica da Expressão Gênica / Proteínas do Grupo Polycomb / Mesilato de Imatinib Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Epigenomics Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Canadá